Terns Pharmaceuticals Stock Market Value
| TERN Stock | USD 4.18 0.28 6.28% |
| Symbol | Terns |
Terns Pharmaceuticals Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Terns Pharmaceuticals. If investors know Terns will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Terns Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Terns Pharmaceuticals is measured differently than its book value, which is the value of Terns that is recorded on the company's balance sheet. Investors also form their own opinion of Terns Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Terns Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Terns Pharmaceuticals' market value can be influenced by many factors that don't directly affect Terns Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Terns Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Terns Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Terns Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Terns Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Terns Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Terns Pharmaceuticals.
| 01/01/2025 |
| 01/31/2025 |
If you would invest 0.00 in Terns Pharmaceuticals on January 1, 2025 and sell it all today you would earn a total of 0.00 from holding Terns Pharmaceuticals or generate 0.0% return on investment in Terns Pharmaceuticals over 30 days. Terns Pharmaceuticals is related to or competes with Collegium Pharmaceutical, Phibro Animal, ANI Pharmaceuticals, Procaps Group, Prestige Brand, Pacira BioSciences,, and Intracellular. Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combin... More
Terns Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Terns Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Terns Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.19) | |||
| Maximum Drawdown | 26.61 | |||
| Value At Risk | (6.75) | |||
| Potential Upside | 5.17 |
Terns Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Terns Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Terns Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Terns Pharmaceuticals historical prices to predict the future Terns Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.13) | |||
| Jensen Alpha | (0.64) | |||
| Total Risk Alpha | (1.14) | |||
| Treynor Ratio | 1.1 |
Terns Pharmaceuticals Backtested Returns
Terns Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.19, which indicates the firm had a -0.19 % return per unit of risk over the last 3 months. Terns Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Terns Pharmaceuticals' Variance of 17.03, risk adjusted performance of (0.13), and Coefficient Of Variation of (597.55) to confirm the risk estimate we provide. The entity has a beta of -0.64, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Terns Pharmaceuticals are expected to decrease at a much lower rate. During the bear market, Terns Pharmaceuticals is likely to outperform the market. At this point, Terns Pharmaceuticals has a negative expected return of -0.8%. Please make sure to validate Terns Pharmaceuticals' maximum drawdown, accumulation distribution, as well as the relationship between the Accumulation Distribution and market facilitation index , to decide if Terns Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.55 |
Modest predictability
Terns Pharmaceuticals has modest predictability. Overlapping area represents the amount of predictability between Terns Pharmaceuticals time series from 1st of January 2025 to 16th of January 2025 and 16th of January 2025 to 31st of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Terns Pharmaceuticals price movement. The serial correlation of 0.55 indicates that about 55.0% of current Terns Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.55 | |
| Spearman Rank Test | 0.16 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Terns Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Terns Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Terns Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Terns Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Terns Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Terns Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Terns Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Terns Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Terns Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Terns Pharmaceuticals Lagged Returns
When evaluating Terns Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Terns Pharmaceuticals stock have on its future price. Terns Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Terns Pharmaceuticals autocorrelation shows the relationship between Terns Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Terns Pharmaceuticals.
Regressed Prices |
| Timeline |
Pair Trading with Terns Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Terns Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Terns Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against Terns Stock
| 0.56 | MLAB | Mesa Laboratories Earnings Call This Week | PairCorr |
| 0.4 | BMY | Bristol Myers Squibb Earnings Call This Week | PairCorr |
| 0.35 | INKT | Mink Therapeutics | PairCorr |
The ability to find closely correlated positions to Terns Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Terns Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Terns Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Terns Pharmaceuticals to buy it.
The correlation of Terns Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Terns Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Terns Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Terns Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Terns Pharmaceuticals Correlation, Terns Pharmaceuticals Volatility and Terns Pharmaceuticals Alpha and Beta module to complement your research on Terns Pharmaceuticals. To learn how to invest in Terns Stock, please use our How to Invest in Terns Pharmaceuticals guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Terns Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.